Literature DB >> 12645650

Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.

Nathalie Wong1, Angela B Y Hui, Boli Fan, Kwok Wai Lo, Elizabeth Pang, Sing-Fai Leung, Dolly P Huang, Philip J Johnson.   

Abstract

Nasopharyngeal carcinoma (NPC) cell lines and xenografts represent valuable models for functional and therapeutic studies on this common malignancy in Southeast Asia. The karyotypic information in most NPC cell lines and xenografts, however, remains largely unclear to date. We have characterized the chromosomal aberrations in six commonly used human NPC cell lines and xenografts using the molecular cytogenetic technique of comparative genomic hybridization (CGH). Genomic imbalances identified in cell lines were further correlated with structural abnormalities indicated from spectral karyotyping (SKY) analysis. CGH revealed consistent overrepresentations of 8q (six out of six cases) with a smallest overlapping region identified on 8q21.1 approximately q22. Other common gains included 7p (4/6 cases), 7q (4/6 cases), 12q (4/6), and 20q (4/6 cases), where minimal overlapping regions were suggested on 7p15 approximately p14, 7q11.2 approximately q21, and 12q22 approximately q24.1. Common losses were detected on 3p12 approximately p21 (4/6 cases) and 11q14 approximately qter (4/6 cases). Although SKY analysis on cell lines revealed predominantly unbalanced rearrangements, reciprocal translocations that involved chromosome 2 [i.e., t(1;2), t(2;3), and t(2;4)] were suggested. Furthermore, SKY examination illustrated additional breakpoints on a number of apparently balanced chromosomes. These breakpoints included 3p21, 3q26, 5q31, 6p21.1 approximately p25, 7p14 approximately p22, and 8q22. Our finding of regional gains and losses and breakpoints represents information that may contribute to NPC studies in vitro.

Entities:  

Mesh:

Year:  2003        PMID: 12645650     DOI: 10.1016/s0165-4608(02)00657-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Authors:  Joanna H Tong; David C Ng; Shuk L Chau; Ken K So; Patrick P Leung; Tin L Lee; Raymond W Lung; Michael W Chan; Anthony W Chan; Kwok W Lo; Ka F To
Journal:  BMC Cancer       Date:  2010-06-03       Impact factor: 4.430

2.  MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma.

Authors:  Qi Tian; Linhui Liang; Jie Ding; Ruopeng Zha; Haibing Shi; Qifeng Wang; Shenglin Huang; Weijie Guo; Chao Ge; Taoyang Chen; Jinjun Li; Xianghuo He
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

3.  Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results.

Authors:  Xin Li; Ena Wang; Ying-dong Zhao; Jia-Qiang Ren; Ping Jin; Kai-Tai Yao; Francesco M Marincola
Journal:  J Transl Med       Date:  2006-01-19       Impact factor: 5.531

4.  miR-145 is differentially regulated by TGF-β1 and ischaemia and targets Disabled-2 expression and wnt/β-catenin activity.

Authors:  Maritza E Mayorga; Marc S Penn
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

Review 5.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

6.  Epstein-Barr virus particles induce centrosome amplification and chromosomal instability.

Authors:  Anatoliy Shumilov; Ming-Han Tsai; Yvonne T Schlosser; Anne-Sophie Kratz; Katharina Bernhardt; Susanne Fink; Tuba Mizani; Xiaochen Lin; Anna Jauch; Josef Mautner; Annette Kopp-Schneider; Regina Feederle; Ingrid Hoffmann; Henri-Jacques Delecluse
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

7.  The progress on genetic analysis of nasopharyngeal carcinoma.

Authors:  Xiaofeng Zhou; Jing Cui; Virgilia Macias; André A Kajdacsy-Balla; Hui Ye; Jianguang Wang; P Nagesh Rao
Journal:  Comp Funct Genomics       Date:  2007

8.  Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.

Authors:  Weiyi Fang; Xin Li; Qingping Jiang; Zhen Liu; Huiling Yang; Shuang Wang; Siming Xie; Qiuzhen Liu; Tengfei Liu; Jing Huang; Weibing Xie; Zuguo Li; Yingdong Zhao; Ena Wang; Francesco M Marincola; Kaitai Yao
Journal:  J Transl Med       Date:  2008-06-20       Impact factor: 5.531

9.  Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.

Authors:  Grace Ty Chung; Raymond Wm Lung; Angela By Hui; Kevin Yl Yip; John Ks Woo; Chit Chow; Carol Yk Tong; Sau-Dan Lee; Jessie Wf Yuen; Samantha Wm Lun; Ken Ky Tso; Nathalie Wong; Sai-Wah Tsao; Timothy Tc Yip; Pierre Busson; Hyungtae Kim; Jeong-Sun Seo; Brian O'Sullivan; Fei-Fei Liu; Ka-Fai To; Kwok-Wai Lo
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

Review 10.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.